|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 83.29 EUR | +0.52% |
|
+9.89% | +20.96% |
| 06-09 | European markets rally - Chipmakers and banks in demand | RE |
| 06-09 | Symrise tops DAX as analysts turn bullish on Givaudan as well | DP |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 3.83B | 4.62B | 4.73B | 5B | 4.93B | |||||
Total Revenues | 3.83B | 4.62B | 4.73B | 5B | 4.93B | |||||
Cost of Goods Sold, Total | 2.35B | 2.92B | 3.04B | 3.04B | 3.07B | |||||
Gross Profit | 1.48B | 1.7B | 1.69B | 1.96B | 1.85B | |||||
Selling General & Admin Expenses, Total | 780M | 935M | 952M | 997M | 994M | |||||
R&D Expenses | 221M | 254M | 266M | 276M | 276M | |||||
Other Operating Expenses | -81.02M | -106M | -60.59M | -18.86M | -24.8M | |||||
Other Operating Expenses, Total | 919M | 1.08B | 1.16B | 1.25B | 1.25B | |||||
Operating Income | 560M | 618M | 536M | 709M | 610M | |||||
Interest Expense, Total | -38.87M | -58.92M | -94.72M | -78.39M | -78.87M | |||||
Interest And Investment Income | 3.6M | 7.8M | 14.61M | 13.28M | 22.03M | |||||
Net Interest Expenses | -35.27M | -51.12M | -80.11M | -65.11M | -56.84M | |||||
Income (Loss) On Equity Invest. | 4.72M | -113M | 9.23M | 5.84M | -144M | |||||
Currency Exchange Gains (Loss) | -7.57M | 200K | 3.1M | -100K | -4.6M | |||||
Other Non Operating Income (Expenses) | 81K | -16.55M | -1.61M | -1.32M | -2.09M | |||||
EBT, Excl. Unusual Items | 522M | 438M | 466M | 649M | 402M | |||||
Merger & Related Restructuring Charges | -5.2M | -3.5M | - | -800K | - | |||||
Gain (Loss) On Sale Of Investments | - | - | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -156K | - | - | 528K | -344K | |||||
Insurance Settlements | - | 2.5M | 14.3M | 2.9M | - | |||||
Other Unusual Items | - | -5.4M | -15.8M | -5.5M | -3.3M | |||||
EBT, Incl. Unusual Items | 516M | 431M | 465M | 646M | 398M | |||||
Income Tax Expense | 131M | 140M | 120M | 164M | 145M | |||||
Earnings From Continuing Operations | 385M | 291M | 345M | 482M | 254M | |||||
Net Income to Company | 385M | 291M | 345M | 482M | 254M | |||||
Minority Interest | -10.11M | -10.69M | -4.47M | -3.73M | -4.24M | |||||
Net Income - (IS) | 375M | 280M | 340M | 478M | 249M | |||||
Net Income to Common Incl Extra Items | 375M | 280M | 340M | 478M | 249M | |||||
Net Income to Common Excl. Extra Items | 375M | 280M | 340M | 478M | 249M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 2.74 | 2 | 2.44 | 3.42 | 1.78 | |||||
Basic EPS - Continuing Operations | 2.74 | 2 | 2.44 | 3.42 | 1.78 | |||||
Basic Weighted Average Shares Outstanding | 137M | 140M | 140M | 140M | 140M | |||||
Net EPS - Diluted | 2.7 | 2 | 2.44 | 3.42 | 1.78 | |||||
Diluted EPS - Continuing Operations | 2.7 | 2 | 2.44 | 3.42 | 1.78 | |||||
Diluted Weighted Average Shares Outstanding | 140M | 140M | 140M | 140M | 140M | |||||
Normalized Basic EPS | 2.31 | 1.88 | 2.05 | 2.87 | 1.77 | |||||
Normalized Diluted EPS | 2.26 | 1.88 | 2.05 | 2.87 | 1.77 | |||||
Dividend Per Share | 1.02 | 1.05 | 1.1 | 1.2 | 1.25 | |||||
Payout Ratio | 35.04 | 50.92 | 43.1 | 32.15 | 67.27 | |||||
American Depositary Receipts Ratio (ADR) | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | |||||
Supplemental Items | ||||||||||
EBITDA | 812M | 908M | 794M | 972M | 736M | |||||
EBITA | 673M | 744M | 649M | 817M | 714M | |||||
EBIT | 560M | 618M | 536M | 709M | 610M | |||||
EBITDAR | 819M | 914M | 802M | 980M | 745M | |||||
Effective Tax Rate - (Ratio) | 25.41 | 32.57 | 25.81 | 25.37 | 36.31 | |||||
Total Current Taxes | 142M | 166M | 132M | 185M | 180M | |||||
Total Deferred Taxes | -10.46M | -25.94M | -11.82M | -21.19M | -34.99M | |||||
Normalized Net Income | 316M | 263M | 287M | 402M | 247M | |||||
Interest Capitalized | 1.2M | 2.2M | 1.9M | 1.5M | 1.6M | |||||
Interest on Long-Term Debt | 8.19M | 2.33M | 2.28M | 9.08M | 8.49M | |||||
Non-Cash Pension Expense | 5.43M | 8.78M | 25.06M | 17.6M | 17.99M | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 564M | 681M | 676M | 699M | 693M | |||||
General and Administrative Expenses | 216M | 254M | 276M | 298M | 301M | |||||
Research And Development Expense From Footnotes | 222M | 256M | 267M | 276M | 276M | |||||
Net Rental Expense, Total | 6.5M | 6.53M | 8.33M | 8.56M | 8.69M | |||||
Imputed Operating Lease Interest Expense | 1.08M | 1.47M | 2.52M | 2.14M | 2.16M | |||||
Imputed Operating Lease Depreciation | 5.43M | 5.06M | 5.81M | 6.41M | 6.53M | |||||
Stock-Based Comp., Other (Total) | - | - | 1.23M | 2.98M | -1.12M | |||||
Total Stock-Based Compensation | - | - | 1.23M | 2.98M | -1.12M |
- Stock Market
- Stocks
- SY1 Stock
- Financials Symrise AG
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















